机译:Tyr-Lock肽结构家族的recifin A,最初的例子是酪氨酸-DNA磷酸二酯酶1的选择性变构抑制剂
Basic Science Program Leidos Biomedical Research Inc. Frederick National Laboratory for Cancer Research Frederick Maryland 21702 United States Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Developmental Therapeutics Branch Laboratory of Molecular Pharmacology NCI NIH Bethesda Maryland 20892 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Developmental Therapeutics Branch Laboratory of Molecular Pharmacology NCI NIH Bethesda Maryland 20892 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Chemical Biology Laboratory Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Developmental Therapeutics Branch Laboratory of Molecular Pharmacology NCI NIH Bethesda Maryland 20892 United States;
School of Biomedical Sciences The University of Queensland Brisbane QLD 4072 Australia;
Institute for Molecular Bioscience The University of Queensland Brisbane QLD 4072 Australia Chemical Biology Laboratory Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States;
Molecular Targets Program Center for Cancer Research NCI-Frederick NIH Frederick Maryland 21702 United States Natural Products Branch Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis National Cancer Institute Frederick Maryland 21702 United States;
机译:actosyl-dna磷酸二酯酶i抑制剂来自家庭的澳大利亚毒素的抑制剂
机译:Toxoflavins和deazaflavins作为第一个报道的酪氨酰DNA磷酸二酯酶II的选择性小分子抑制剂
机译:发现在骨关节炎疼痛模型中具有活性的有效的,选择性的,可生物利用的磷酸二酯酶2(PDE2)抑制剂,第一部分:将选择性吡唑并二氮杂酮磷酸二酯酶4(PDE4)抑制剂转变为选择性PDE2抑制剂
机译:一种选择性地抑制ΔPKC函数之一的新型变形肽的合理设计
机译:基于蛋白质的人酪氨酰-DNA磷酸二酯酶抑制剂的计算和组合设计。
机译:通过靶向酶结合DNA的裂口发现酪氨酸-DNA磷酸二酯酶2的选择性抑制剂
机译:Tyrosyl-DNA磷酸二酯酶I的选择性变构抑制剂的recifin A,Tyr-Lock肽结构家族的最初实例